Smith & Nephew SNATS Quick Ratio 2010-2023 | SNN
Historical quick ratio values for Smith & Nephew SNATS (SNN) over the last 10 years.
| Smith & Nephew SNATS Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2023-12-31 | $1.64B | $2.27B | 0.72 |
| 2023-06-30 | $1.47B | $1.77B | 0.83 |
| 2022-12-31 | $1.65B | $1.72B | 0.96 |
| 2022-06-30 | $1.77B | $2.12B | 0.84 |
| 2021-12-31 | $2.58B | $2.13B | 1.21 |
| 2021-06-30 | $2.69B | $2.12B | 1.27 |
| 2020-12-31 | $2.97B | $1.69B | 1.76 |
| 2020-06-30 | $1.58B | $1.52B | 1.04 |
| 2019-12-31 | $1.61B | $1.56B | 1.03 |
| 2019-06-30 | $1.42B | $1.47B | 0.96 |
| 2018-12-31 | $1.68B | $1.47B | 1.15 |
| 2018-06-30 | $1.30B | $1.25B | 1.05 |
| 2017-12-31 | $1.43B | $1.35B | 1.06 |
| 2017-06-30 | $1.28B | $1.19B | 1.08 |
| 2016-12-31 | $1.29B | $1.35B | 0.95 |
| 2015-12-31 | $1.26B | $1.34B | 0.94 |
| 2015-06-30 | $1.25B | $1.23B | 1.02 |
| 2014-12-31 | $1.26B | $1.16B | 1.08 |
| 2014-09-30 | $1.32B | $1.23B | 1.08 |
| 2014-06-30 | $1.35B | $1.15B | 1.17 |
| 2014-03-31 | $1.32B | $1.06B | 1.24 |
| 2013-12-31 | $1.25B | $1.07B | 1.17 |
| 2013-09-30 | $1.19B | $1.03B | 1.16 |
| 2013-06-30 | $1.15B | $0.89B | 1.29 |
| 2013-03-31 | $1.16B | $0.92B | 1.26 |
| 2012-12-31 | $1.24B | $0.93B | 1.34 |
| 2012-09-30 | $1.40B | $0.91B | 1.54 |
| 2012-06-30 | $1.22B | $0.80B | 1.53 |
| 2012-03-31 | $1.43B | $1.03B | 1.40 |
| 2011-12-31 | $1.35B | $1.14B | 1.18 |
| 2011-09-30 | $1.32B | $1.29B | 1.02 |
| 2011-06-30 | $1.30B | $1.35B | 0.96 |
| 2011-03-31 | $1.27B | $0.88B | 1.44 |
| 2010-12-31 | $1.23B | $0.91B | 1.35 |
| 2010-09-30 | $1.40B | $0.86B | 1.62 |
| 2010-06-30 | $1.24B | $0.78B | 1.59 |
| 2010-03-31 | $1.18B | $0.88B | 1.34 |
| 2009-12-31 | $1.15B | $0.86B | 1.34 |
| 2009-09-30 | $1.16B | $0.91B | 1.28 |
| 2009-06-30 | $1.12B | $0.88B | 1.27 |
| 2009-03-31 | $1.09B | $1.00B | 1.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.391B | $5.549B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.326B | 24.57 |
| Stryker (SYK) | United States | $130.140B | 32.27 |
| Medtronic (MDT) | Ireland | $106.398B | 15.06 |
| Boston Scientific (BSX) | United States | $99.865B | 33.21 |
| EssilorLuxottica (ESLOY) | France | $97.453B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.386B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.575B | 28.61 |
| ResMed (RMD) | United States | $27.338B | 27.33 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.576B | 16.47 |
| Terumo (TRUMY) | Japan | $24.984B | 35.28 |
| Baxter (BAX) | United States | $20.481B | 14.94 |
| Koninklijke Philips (PHG) | Netherlands | $18.629B | 14.86 |
| Insulet (PODD) | United States | $12.269B | 64.42 |
| Demant (WILYY) | Denmark | $10.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.568B | 25.53 |
| BellRing Brands (BRBR) | United States | $7.201B | 38.72 |
| Haemonetics (HAE) | United States | $4.328B | 22.14 |
| Lantheus Holdings (LNTH) | United States | $4.167B | 10.76 |
| Perrigo (PRGO) | Ireland | $4.109B | 11.75 |
| GN Store Nord (GNNDY) | Denmark | $3.721B | 24.09 |
| Prestige Consumer Healthcare (PBH) | United States | $3.388B | 16.02 |
| Envista Holdings (NVST) | United States | $3.296B | 12.54 |
| QuidelOrtho (QDEL) | United States | $2.820B | 10.23 |
| Green Thumb Industries (GTBIF) | United States | $2.682B | 85.00 |
| Neogen (NEOG) | United States | $2.682B | 25.79 |
| ICU Medical (ICUI) | United States | $2.393B | 17.85 |
| TG Therapeutics (TGTX) | United States | $2.187B | 708.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.112B | 0.00 |
| Owens & Minor (OMI) | United States | $1.959B | 18.81 |
| Verano Holdings (VRNOF) | United States | $1.745B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.658B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.529B | 47.61 |
| InMode (INMD) | Israel | $1.505B | 7.79 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.89 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.84 |
| Warby Parker (WRBY) | United States | $1.301B | 0.00 |
| AtriCure (ATRC) | United States | $1.165B | 0.00 |
| MacroGenics (MGNX) | United States | $1.097B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.747B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.711B | 0.00 |
| Evolus (EOLS) | United States | $0.701B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.700B | 15.13 |
| Quanterix (QTRX) | United States | $0.699B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| Valneva SE (VALN) | France | $0.591B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.531B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.524B | 0.00 |
| PetIQ (PETQ) | United States | $0.484B | 18.09 |
| Jin Medical (ZJYL) | China | $0.481B | 0.00 |
| Biote (BTMD) | United States | $0.449B | 4.27 |
| ZimVie (ZIMV) | United States | $0.433B | 26.50 |
| OraSure Technologies (OSUR) | United States | $0.422B | 6.99 |
| Surmodics (SRDX) | United States | $0.384B | 41.54 |
| Zynex (ZYXI) | United States | $0.383B | 44.11 |
| Aurora Cannabis (ACB) | Canada | $0.360B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 31.46 |
| Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.02 |
| Veru (VERU) | United States | $0.223B | 0.00 |
| Omeros (OMER) | United States | $0.218B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 20.89 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.109B | 9.33 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Safety Shot (SHOT) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.102B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Chimerix (CMRX) | United States | $0.086B | 0.00 |
| Brainsway (BWAY) | Israel | $0.086B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.89 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 13.66 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.026B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.021B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |